Diagnostic and prognostic significance of human kallikrein 11 (KLK11) mRNA expression levels in patients with laryngeal cancer

Clinical Biochemistry

Volumn 45, Issue 9, 2012, Pages 623-630

  Patsis, Christos ^a   Yiotakis, Ioannis ^b   Scorilas, Andreas ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Diagnosis; Kallikreins; KLK11; Laryngeal cancer; LSCC; Molecular tumor markers; Prognosis

Indexed keywords

KALLIKREIN; KALLIKREIN 11; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; GREEN CHEMISTRY; HUMAN; HUMAN CELL; HUMAN TISSUE; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORESCENT DYES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; ORGANIC CHEMICALS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RNA, MESSENGER; ROC CURVE; SERINE ENDOPEPTIDASES; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84861233755     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.03.005     Document Type: Article

References (37)

1. Pignataro L., Sambataro G., Pagani D., Pruneri G. Clinico-prognostic value of D-type cyclins and p27 in laryngeal cancer patients: a review. Acta Otorhinolaryngol Ital 2005, 25:75-85.
2. Licitra L., Bernier J., Grandi C., Locati L., Merlano M., Gatta G., et al. Cancer of the larynx. Crit Rev Oncol Hematol 2003, 47:65-80.
3. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN. Int J Cancer 2008, 127:2893-2917.
4. Marioni G., Marchese-Ragona R., Cartei G., Marchese F., Staffieri A. Current opinion in diagnosis and treatment of laryngeal carcinoma. Cancer Treat Rev 2006, 32:504-515.
5. Hardisson D. Molecular pathogenesis of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 2003, 260:502-508.
6. Rodrigo J.P., Ferlito A., Suarez C., Shaha A.R., Silver C.E., Devaney K.O., et al. New molecular diagnostic methods in head and neck cancer. Head Neck 2005, 27:995-1003.
7. Almadori G., Bussu F., Cadoni G., Galli J., Paludetti G., Maurizi M. Molecular markers in laryngeal squamous cell carcinoma: towards an integrated clinicobiological approach. Eur J Cancer 2005, 41:683-693.
8. Nadal A., Cardesa A. Molecular biology of laryngeal squamous cell carcinoma. Virchows Arch 2003, 442:1-7.
9. Vlachtsis K., Nikolaou A., Markou K., Fountzilas G., Daniilidis I. Clinical and molecular prognostic factors in operable laryngeal cancer. Eur Arch Otorhinolaryngol 2005, 262:890-898.
10. Yousef G.M., Chang A., Scorilas A., Diamandis E.P. Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4. Biochem Biophys Res Commun 2000, 276:125-133.
11. Emami N., Diamandis E.P. New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family. Mol Oncol 2007, 1:269-287.
12. Borgono C.A., Michael I.P., Diamandis E.P. Human tissue kallikreins: physiologic roles and applications in cancer. Mol Cancer Res 2004, 2:257-280.
13. Mavridis K., Scorilas A. Prognostic value and biological role of the kallikrein-related peptidases in human malignancies. Future Oncol 2010, 6:269-285.
14. Yoshida S., Taniguchi M., Suemoto T., Oka T., He X., Shiosaka S. cDNA cloning and expression of a novel serine protease, TLSP. Biochim Biophys Acta 1998, 1399:225-228.
15. Yousef G.M., Scorilas A., Diamandis E.P. Genomic organization, mapping, tissue expression, and hormonal regulation of trypsin-like serine protease (TLSP PRSS20), a new member of the human kallikrein gene family. Genomics 2000, 63:88-96.
16. Mitsui S., Yamada T., Okui A., Kominami K., Uemura H., Yamaguchi N. A novel isoform of a kallikrein-like protease, TLSP/hippostasin, (PRSS20), is expressed in the human brain and prostate. Biochem Biophys Res Commun 2000, 272:205-211.
17. Nakamura T., Mitsui S., Okui A., Kominami K., Nomoto T., Ukimura O., et al. Alternative splicing isoforms of hippostasin (PRSS20/KLK11) in prostate cancer cell lines. Prostate 2001, 49:72-78.
18. Nakamura T., Mitsui S., Okui A., Miki T., Yamaguchi N. Molecular cloning and expression of a variant form of hippostasin/KLK11 in prostate. Prostate 2003, 54:299-305.
19. Luo L.Y., Shan S.J., Elliott M.B., Soosaipillai A., Diamandis E.P. Purification and characterization of human kallikrein 11, a candidate prostate and ovarian cancer biomarker, from seminal plasma. Clin Cancer Res 2006, 12:742-750.
20. Diamandis E.P., Okui A., Mitsui S., Luo L.Y., Soosaipillai A., Grass L., et al. Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma. Cancer Res 2002, 62:295-300.
21. Lallemant B., Evrard A., Combescure C., Chapuis H., Chambon G., Raynal C., et al. Reference gene selection for head and neck squamous cell carcinoma gene expression studies. BMC Mol Biol 2009, 10:78.
22. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
23. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet] 2010, International Agency for Research on Cancer, Lyon, France, Available from:. http://globocan.iarc.fr.
24. Petraki C.D., Papanastasiou P.A., Karavana V.N., Diamandis E.P. Cellular distribution of human tissue kallikreins: immunohistochemical localization. Biol Chem 2006, 387:653-663.
25. Sasaki H., Kawano O., Endo K., Suzuki E., Haneda H., Yukiue H., et al. Decreased kallikrein 11 messenger RNA expression in lung cancer. Clin Lung Cancer 2006, 8:45-48.
26. Borgono C.A., Diamandis E.P. The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer 2004, 4:876-890.
27. Roman-Gomez J., Jimenez-Velasco A., Agirre X., Castillejo J.A., Barrios M., Andreu E.J., et al. The normal epithelial cell-specific 1 (NES1) gene, a candidate tumor suppressor gene on chromosome 19q13.3-4, is downregulated by hypermethylation in acute lymphoblastic leukemia. Leukemia 2004, 18:362-365.
28. Pampalakis G., Diamandis E.P., Sotiropoulou G. The epigenetic basis for the aberrant expression of kallikreins in human cancers. Biol Chem 2006, 387:795-799.
29. Scorilas A., Gregorakis A.K. mRNA expression analysis of human kallikrein 11 (KLK11) may be useful in the discrimination of benign prostatic hyperplasia from prostate cancer after needle prostate biopsy. Biol Chem 2006, 387:789-793.
30. Bi X., He H., Ye Y., Dai Q., Han Z., Liang Y., et al. Association of TMPRSS2 and KLK11 gene expression levels with clinical progression of human prostate cancer. Med Oncol 2010, 27:145-151.
31. Borgono C.A., Fracchioli S., Yousef G.M., Rigault de la Longrais I.A., Luo L.Y., Soosaipillai A., et al. Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma. Int J Cancer 2003, 106:605-610.
32. Diamandis E.P., Borgono C.A., Scorilas A., Harbeck N., Dorn J., Schmitt M. Human kallikrein 11: an indicator of favorable prognosis in ovarian cancer patients. Clin Biochem 2004, 37:823-829.
33. Yoon H., Laxmikanthan G., Lee J., Blaber S.I., Rodriguez A., Kogot J.M., et al. Activation profiles and regulatory cascades of the human kallikrein-related peptidases. J Biol Chem 2007, 282:31852-31864.
34. Beaufort N., Plaza K., Utzschneider D., Schwarz A., Burkhart J.M., Creutzburg S., et al. Interdependence of kallikrein-related peptidases in proteolytic networks. Biol Chem 2010, 391:581-587.
35. Liu W.W., Zeng Z.Y., Wu Q.L., Hou J.H., Chen Y.Y. Overexpression of MMP-2 in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis. Otolaryngol Head Neck Surg 2005, 132:395-400.
36. Yuce I., Bayram A., Cagli S., Canoz O., Bayram S., Guney E. The role of CD44 and matrix metalloproteinase-9 expression in predicting neck metastasis of supraglottic laryngeal carcinoma. Am J Otolaryngol 2011, 32:141-146.
37. McIntosh M.W., Liu Y., Drescher C., Urban N., Diamandis E.P. Validation and characterization of human kallikrein 11 as a serum marker for diagnosis of ovarian carcinoma. Clin Cancer Res 2007, 13:4422-4428.